Prevalence of PD-L1 expression in SCLC, however, is prominently lower at baseline, with one study finding less than 20% of the patients with positive expression as compared to NSCLC, where PD-L1 prevalence is much higher at 52%-67%[52-55]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.